PharmaEngine Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	1,504	993.7	875.62	1,769	2,151	1,836
Short-Term Investments	3,087	2,867	2,752	1,837	1,663	1,558
Trading Asset Securities	-	-	-	55.59	-	-
Cash & Short-Term Investments	4,591	3,861	3,628	3,661	3,814	3,394
Cash Growth	22.69%	6.42%	-0.91%	-4.00%	12.37%	-0.64%
Accounts Receivable	204.11	1,844	174.17	160.34	160.48	644.52
Other Receivables	64.91	87.59	97.41	63.51	22.83	95.81
Receivables	269.02	1,932	271.58	223.85	183.31	740.33
Inventory	22	28.38	15.9	34.38	5.43	24.74
Prepaid Expenses	8.39	6.4	7.48	6.57	6.48	10.56
Other Current Assets	-	-	-	-	0.08	0.48
Total Current Assets	4,890	5,827	3,923	3,926	4,009	4,170
Property, Plant & Equipment	5.47	10.24	18.03	25.92	7.89	22.95
Other Intangible Assets	1.25	1.78	1.88	2.51	0.6	0.83
Long-Term Deferred Tax Assets	8.29	5.91	8	9.54	4.98	6.84
Other Long-Term Assets	2.33	2.44	2.98	2.5	3.9	6.44
Total Assets	4,908	5,848	3,954	3,967	4,026	4,207
Accrued Expenses	76.03	99.31	67.22	61.31	64.14	48.22
Current Portion of Leases	2.11	7.14	7.67	7.54	7.59	10.77
Current Income Taxes Payable	25.93	327.9	-	-	6.92	34.69
Other Current Liabilities	8.26	8.7	8.98	9.9	9.06	90.78
Total Current Liabilities	112.33	443.05	83.86	78.74	87.71	184.46
Long-Term Leases	0.52	-	7.14	14.81	-	11.31
Long-Term Deferred Tax Liabilities	-	4.96	-	0.92	-	0
Total Liabilities	112.86	448.01	91.01	94.47	87.71	195.78
Common Stock	1,457	1,457	1,457	1,457	1,466	1,466
Additional Paid-In Capital	1,616	1,616	1,616	1,617	1,620	1,620
Retained Earnings	1,856	2,461	925.31	937.85	1,101	1,039
Treasury Stock	-133.41	-133.41	-133.41	-133.41	-248.24	-114.83
Comprehensive Income & Other	-	-0.41	-1.79	-5.97	-	1.21
Shareholders' Equity	4,795	5,400	3,863	3,872	3,939	4,011
Total Liabilities & Equity	4,908	5,848	3,954	3,967	4,026	4,207
Total Debt	2.64	7.14	14.81	22.35	7.59	22.08
Net Cash (Debt)	4,588	3,854	3,613	3,639	3,806	3,372
Net Cash Growth	22.92%	6.65%	-0.71%	-4.39%	12.88%	-0.33%
Net Cash Per Share	31.86	26.78	25.14	25.32	26.30	23.11
Filing Date Shares Outstanding	143.68	143.68	143.68	143.69	143.6	145.6
Total Common Shares Outstanding	143.68	143.68	143.68	143.69	143.6	145.6
Working Capital	4,778	5,384	3,839	3,847	3,921	3,985
Book Value Per Share	33.37	37.58	26.89	26.95	27.43	27.55
Tangible Book Value	4,794	5,398	3,861	3,870	3,938	4,010
Tangible Book Value Per Share	33.36	37.57	26.87	26.93	27.42	27.54
Machinery	5.47	5.18	4.44	4.03	0.8	4.97
Leasehold Improvements	-	-	7.69	7.69	7.69	9.61

Source: S&P Global Market Intelligence. Standard template. Financial Sources.